There are currently no generic versions of Tasmar (tolcapone). The earliest predictable date that a generic version could become available is December 2012, when the next patent for the drug expires. It is important to note that tolcapone is the "generic name" for Tasmar; it is not a generic version of it.
Tasmar is made by Legacy Pharmaceuticals (for the 100 mg tablets) or Hoffmann-La Roche, Inc. (for the 200 mg tablets) and marketed by Valeant Pharmaceuticals North America. At this time, no generic Tasmar is available in the United States.
When Will Generic Tasmar Be Available?
The first patent for Tasmar expired in January 2012. However, the drug is not yet available in generic form. Most likely, this means that at least one other, later-expiring patent is still protecting the medication from generic competition. The next Tasmar patent is set to expire in December 2012. This is the earliest predictable date that a generic version could become available.
However, other circumstances could arise to extend or shorten the exclusivity period. This could include such things as lawsuits or other patents for specific Tasmar uses. Once the patent expires, several companies likely will begin manufacturing a generic Tasmar drug.
Is Tolcapone the Same as Generic Tasmar?
No -- tolcapone is the active ingredient in Tasmar, but it is not a generic version of it. What can be confusing is that, oftentimes, the active ingredient of a drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Tasmar [package insert]. Bridgewater, NJ: Valeant Pharmaceuticals North America LLC;2013 May.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed March 8, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click